References

Systems biology: a brief overview

10.1126/science.1069492 · 2002 · External reference

Systems biology in immunology: a computational modeling perspective

10.1146/annurev-immunol-030409-101317 · 2011 · External reference

Systems immunology: just getting started

10.1038/ni.3768 · 2017 · External reference

Integrative omics for health and disease

10.1038/nrg.2018.4 · 2018 · External reference

Network biology: understanding the cell’s functional organization

10.1038/nrg1272 · 2004 · External reference

Human immune system variation

10.1038/nri.2016.125 · 2017 · External reference

The pathogenesis of rheumatoid arthritis

10.1056/nejmra1004965 · 2011 · External reference

Immunopathogenesis of rheumatoid arthritis

10.1016/j.immuni.2017.02.006 · 2017 · External reference

Origin and physiological roles of inflammation

10.1038/nature07201 · 2008 · External reference

Stress, inflammation, and defense of homeostasis

10.1016/j.molcel.2014.03.030 · 2014 · External reference

Human immune diversity: from evolution to modernity

10.1038/s41590-021-01058-1 · 2021 · External reference

Continuous immunotypes describe human immune variation and predict diverse responses

10.1073/pnas.1705065114 · 2017 · External reference

Global analyses of human immune variation reveal baseline predictors of postvaccination responses

10.1016/j.cell.2014.03.031 · 2014 · External reference

Host and environmental factors influencing individual human cytokine responses

10.1016/j.cell.2016.10.018 · 2016 · External reference

The hygiene hypothesis in autoimmunity: the role of pathogens and commensals

10.1038/nri.2017.111 · 2018 · External reference

Hygiene hypothesis and autoimmune diseases

10.1007/s12016-011-8285-8 · 2012 · External reference

The “hygiene hypothesis” and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland

10.1111/apm.12023 · 2013 · External reference

The microbiome in inflammatory bowel disease: current status and the future ahead

10.1053/j.gastro.2014.02.009 · 2014 · External reference

Human gut microbiome viewed across age and geography

10.1038/nature11053 · 2012 · External reference

JAKs and STATs in immunity, immunodeficiency, and cancer

10.1056/nejmra1202117 · 2013 · External reference

The PI3K pathway in human disease

10.1016/j.cell.2017.07.029 · 2017 · External reference

NF-κB signaling in inflammation

10.1038/sigtrans.2017.23 · 2017 · External reference

Mechanisms and consequences of Jak–STAT signaling in the immune system

10.1038/ni.3691 · 2017 · External reference

Trained immunity: a program of innate immune memory in health and disease

10.1126/science.aaf1098 · 2016 · External reference

Defining trained immunity and its role in health and disease

10.1038/s41577-020-0285-6 · 2020 · External reference

Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes

10.1016/j.chom.2012.06.006 · 2012 · External reference

Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity

10.1126/science.1251086 · 2014 · External reference

Precision medicine and management of rheumatoid arthritis

10.1016/j.jaut.2020.102405 · 2020 · External reference

Systemic sclerosis

10.1038/nrdp.2015.2 · 2015 · External reference

The biology of physiological health

10.1016/j.cell.2020.03.036 · 2020 · External reference

Reframing immune-mediated inflammatory diseases through signature cytokine hubs

10.1056/nejmra1909094 · 2021 · External reference

Ankylosing spondylitis and axial spondyloarthritis

10.1038/nrrheum.2016.13 · 2016 · External reference

The pathogenesis of psoriatic arthritis

10.1016/s0140-6736(18)30830-4 · 2018 · External reference

Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research Cohort of patients with systemic sclerosis

10.1002/art.40906 · 2019 · External reference

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis

10.1002/art.24038 · 2008 · External reference

Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases

10.37897/rjr.2023.3.7 · 2023 · External reference

Data from the Romanian Registry of Rheumatic Diseases for patients with psoriatic arthritis treated with biologic and targeted-synthetic disease-modifying anti-rheumatic drugs – 2023 update

10.37897/rjr.2024.33.1.1 · 2024 · External reference

Treatment of axial spondyloarthritis patients with biologic disease-modifying anti-rheumatic drugs in 2022 – data from the Romanian Registry of Rheumatic Diseases

10.37897/rjr.2023.4.4 · 2023 · External reference

Genetics of rheumatoid arthritis contributes to biology and drug discovery

10.1038/nature12873 · 2014 · External reference

Multi-omics data integration, interpretation, and its application

10.1177/1177932219899051 · 2020 · External reference

WDR54 enhances NF-κB signaling to promote progression of hepatocellular carcinoma

10.1016/j.cancergen.2025.11.007 · 2025 · External reference

A dynamic vascular–inflammatory–fibrotic loop in systemic sclerosis: an integrative immuno-vascular framework

10.3389/fimmu.2026.1784630 · 2026 · External reference

Recent advances in the genetics of rheumatoid arthritis

10.1038/nrrheum.2011.111 · 2011 · External reference

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

10.1038/ng.3528 · 2016 · External reference

Multi-omics approaches to disease

10.1186/s13059-017-1215-1 · 2017 · External reference

Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration

10.1016/j.cancergen.2025.08.010 · 2025 · External reference

Precision medicine—personalized, problematic, and promising

10.1056/nejmsb1503104 · 2015 · External reference

The trinity of COVID-19: immunity, inflammation and intervention

10.1038/s41577-020-0311-8 · 2020 · External reference

COVID-19: consider cytokine storm syndromes and immunosuppression

10.1016/s0140-6736(20)30628-0 · 2020 · External reference

Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions

10.1136/annrheumdis-2016-209201 · 2016 · External reference

Fingerprints evaluation in systemic sclerosis

10.4323/rjlm.2010.155 · 2010 · External reference